ClinicalTrials.gg
Sign In

Drug

LAM-001 clinical trials

Also written LAM-001.

studies test it
3
open now
3
in phase 3
0
first study started
2023

Keep track of what changes. Save the LAM-001 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

LAM-001
3

Studies by the year they started

3 studies that test it; most in 2023 (2)

Studies that test LAM-001, by start year
YearStudies
20232
20261

By phase

A phase 1/2 study counts in both.

Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it.

Sarcoidosis
1
Hypoxia
1
Bronchiolitis Obliterans Syndrome
1

Who runs them

Industry 2 · Other 1

IRulya Therapeutics Inc. (2) · Steven Hays, MD (1)

Studies

Open first, then newest update. How each study uses LAM-001 is read from its arms, and is right about nine times in ten.

Testing it · 3